TrialOrphanet journal of rare diseases2019
Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1.
M Judith Peterschmitt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled ittrialcites it